Editorial response: Community-acquired methicillin-resistant Staphylococcus aureus infections - Where do we go from here?

Clinical Infectious Diseases

Volumn 29, Issue 4, 1999, Pages 801-802

  Kak, Vivek ^a   Levine, Donald P ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DETROIT RECEIVING HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE; QUINOLONE DERIVATIVE; VANCOMYCIN;

ANTIMICROBIAL ACTIVITY; BACTEREMIA; CLINICAL PRACTICE; EDITORIAL; ENDEMIC DISEASE; ENTEROCOCCUS; FATALITY; HUMAN; HYDROLYSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIA;

EID: 0033509737     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520438     Document Type: Editorial

References (21)

1. Rammelkamp CH, Maxon T. Resistance of Staphylococcus aureus to the action of penicillin. Proc Soc Exp Biol Med 1942;51:386.
2. Bondi A Jr, Dietz CC, Penicillin resistant staphylococci. Proc Soc Exp Biol Med 1945;60:55.
3. Barrett FF, Casey JI, Wilcox C, et al. Bacteriophage types and antibiotic susceptibility of Staphylococcus aureus: Boston City Hospital, 1967. Arch Intern Med 1970;125:867.
4. Barrett FF, McGehee RF Jr, Finland M, Methicillin-resistant Staphylococcus aureus at Boston City Hospital: bacteriologic and epidemiologic observations. N Engl J Med 1968;279:441-8.
5. Thompson RL, Cabezudo I, Wenzel RP. Epidemiology of nosocomial infections caused by methicillin resistant Staphylococcus aureus. Ann Intern Med 1982;97:309-17.
6. Levine DP, Cushing RD, Jui J, Brown WJ. Community acquired methicillin resistant Staphylococcus aureus endocarditis in the Detroit Medical Center. Ann Intern Med 1982;97:330-9.
7. Saravolatz LD, Pohlod DJ, Arking LM. Community acquired methicillin resistant Staphylococcus aureus: a new source for nosocomial outbreaks. Ann Intern Med 1982;97:325-9.
8. Saravolatz LD, Markowitz N, Arking L, Pohlod D, Fisher E. Methicillin resistant Staphylococcus aureus: epidemiologic observations during a community acquired outbreak. Ann Intern Med 1982;96:11-6.
9. Panlilo AL, Culver DH, Gaynes RP, et al. Methicillin resistant Staphylococcus aureus in U.S. hospitals 1975-1991. Infect Control Hosp Epiderniol 1992;13:582-6.
10. Moreno F, Crisp C, Jorgenson JH, Patterson JE. Methicillin-resistant Staphylococcus aureus as a community organism. Clin Infect Dis 1995; 21:1308-12.
11. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998;279:593-8.
12. Lindenmayer JM, Schoenfeld S, O'Grady R, Carney JK. Methicillin resistant Staphylococcus aureus in a high school wrestling team and the surrounding community. Arch intern Med 1998;158:895-9.
13. Maquire GP, Arthur AD, Boustead PJ, Dwyer B, Currie BJ. Community-acquired methicillin resistant Staphylococcus aureus in the Northern Territory. Medical Journal of Australia 1996;164:721-3.
14. Embil J, Romatar K, Romance L, et al. Methicillin resistant Staphylococcus aureus in tertiary care institutions on the Canadian prairies 1990-1992. Infect Control Epidemiol 1994; 15:646-51.
15. Gorak EJ, Yamada SM, Brown JD. Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. Clin Infect Dis 1999:29:797-800.
16. Frank AL, Marcinak JF, Mangat PD, Schreckenberger PC. Increase in community-acquired methicillin-resistant Staphylococcus aureus in children. Clin Infect Dis 1999;29:935-6.
17. Abi-Hanna P, Frank AL, Marcinak JF, Quinn J, Schreckenberger PC, Clonal features of community-acquired methicillin resistant Staphylococcus aureus in children, Chicago 1987-97 [abstract no C-079]. In: Program and abstracts of the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1998:91.
18. Smith TH, Pearson ML, Wilcox KR, et al. Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 1999;340:493-501.
19. Markowitz N, Quinn EL, Saravolatz LD. Trimethoprim-sulfamethoxazole compared with vancomycin for treatment of Staphylococcus aureus Infection. Ann Intern Med 1992;117:390-8.
20. Karam CM, McKinnon PS, Rybak MJ, Risk factors for methicillin resistant Staphylococcus aureus bacteremia [abstract no K-36]. In: Program and abstracts of the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1998:91.
21. Aubry-Damon H, Legrand P, Brun-Buisson C, et al. Reemergence of gentamicin-susceptible strains of methicillin-resistant Staphylococcus aureus: roles of an infection control program and changes in aminoglycoside use. Clin Infect Dis 1997;25:647-53.